Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 20/20 | 0.74 |
| ▸ | NR3C2 | P08235 | 14/20 | 0.74 |
| ▸ | PGR | P06401 | 11/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL290986 | 1.00 | NR3C1 (0.74) | NR3C1NR3C2PGR | |
| SCHEMBL299481 | 0.90 | NR3C1 (0.61) | NR3C1NR3C2PGR | |
| SCHEMBL291819 | 0.89 | NR3C1 (0.79) | NR3C1NR3C2PGR | |
| SCHEMBL290957 | 0.89 | NR3C1 (0.73) | NR3C1NR3C2PGR | |
| SCHEMBL292519 | 0.89 | NR3C1 (0.79) | NR3C1NR3C2PGR | |
| SCHEMBL292472 | 0.88 | NR3C1 (0.78) | NR3C1NR3C2PGR | |
| SCHEMBL9987941 | 0.88 | NR3C1 (0.74) | NR3C1NR3C2PGR | |
| SCHEMBL290955 | 0.85 | NR3C1 (1.00) | NR3C1NR3C2PGR | |
| SCHEMBL4942962 | 0.85 | NR3C1 (0.58) | NR3C1NR3C2PGR | |
| SCHEMBL291977 | 0.84 | NR3C1 (0.54) | NR3C1NR3C2PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110105559-A1 | Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy | WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.) | 2011-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105559-A1 | Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy | CYSLTR1, LTB4R, CYSLTR2 | NR3C1 18/4885NR3C2 87/4885PGR 123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.